News archive
320 results
-
Fimea and Valvira provide pharmacies and physicians with guidance on conditions for prescription of ADHD medication and Sic notations
-
Fimea’s final accounts and annual report for 2020 are also published online
-
Fimea's new strategy focuses on cooperation and development
-
Training modules for the Clinical Trials Information System (CTIS) portal have been published
-
Webpage detailing adverse reaction reports of corona vaccines has been opened
-
Fimea told of first deaths among recipients of COVID-19 vaccine
-
Reminder: EMA to organise CTIS programme training for non-commercial operators
-
Fimea and THL closely monitor adverse effects and safety of coronavirus vaccines – no unexpected side effects have emerged
-
Report on medicines data repository completed
-
Brexit agreement and pharmaceutical imports from 1.1.2021
-
Coronavirus vaccines are introduced in the EU through the marketing authorisation process
-
Medicines cannot be purchased from Great Britain by mail starting from 1 January 2021
-
Guidelines for when the Brexit transition period ends on 31 December 2020
-
EMA to organise CTIS programme training for non-commercial operators
-
Medicines cannot be purchased from the UK by mail after no-deal Brexit
-
Fimea hosts an international training event for GMP inspectors on 8–10 December
-
Piloting of the EU Regulation on Clinical Trials has commenced in Finland
-
Shortages in supply reported by marketing authorisation holders published as open data
-
FimeaWeb medicine search has been updated
-
‘Every report counts’ – a call to report suspected side effects
Showing 201 - 220 / 320
